Impact of a Prescriber-driven Antibiotic Time-out on Antibiotic Use in Hospitalized Patients.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
24 04 2019
Historique:
received: 11 07 2018
accepted: 26 11 2018
pubmed: 6 12 2018
medline: 3 7 2020
entrez: 6 12 2018
Statut: ppublish

Résumé

A multicenter quasi-experimental study of a provider-driven antibiotic "time-out" in 3470 antibiotic courses showed no difference in antibiotic use before and after implementation, but did show a decrease in inappropriate therapy (45% vs 31%, P < .05). Single time-outs without input from antibiotic stewardship teams are insufficient to optimize prescribing.

Identifiants

pubmed: 30517592
pii: 5230122
doi: 10.1093/cid/ciy852
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1581-1584

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Kerri A Thom (KA)

Department of Epidemiology, University of Maryland School of Medicine, Baltimore.

Pranita D Tamma (PD)

Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore.

Anthony D Harris (AD)

Department of Epidemiology, University of Maryland School of Medicine, Baltimore.

Kathryn Dzintars (K)

Department of Pharmacy, Johns Hopkins Hospital, Baltimore.

Daniel J Morgan (DJ)

Department of Epidemiology, University of Maryland School of Medicine, Baltimore.
Veterans Affairs Maryland Health Care System, Baltimore.

Shanshan Li (S)

MassMutual Data Science, Springfield, Massachusetts.

Lisa Pineles (L)

Department of Epidemiology, University of Maryland School of Medicine, Baltimore.

Arjun Srinivasan (A)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Edina Avdic (E)

Department of Pharmacy, Johns Hopkins Hospital, Baltimore.

Sara E Cosgrove (SE)

Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH